SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-041065
Filing Date
2007-02-27
Accepted
2007-02-27 16:25:25
Documents
3
Period of Report
2007-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 18270
2 OPTION AND LICENSE AGREEMENT dex10242.htm EX-10.242 168721
3 PRESS RELEASE dex991.htm EX-99.1 14554
  Complete submission text file 0001193125-07-041065.txt   203080
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27570 | Film No.: 07653576
SIC: 8731 Services-Commercial Physical & Biological Research